{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:30:11Z","timestamp":1787851811030,"version":"build-2784847793"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["32160171"],"award-info":[{"award-number":["32160171"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002701","name":"Ministry of Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002701","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijbiomac.2026.153252","type":"journal-article","created":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T16:11:39Z","timestamp":1783699899000},"page":"153252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multi-omics integration combined with multi-source weighted analysis identifies a key microRNA combination that reverses \u03b1-synuclein aggregation and pathological phenotypes in Parkinson's disease"],"prefix":"10.1016","volume":"375","author":[{"given":"Guodong","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caihong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinxin","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinmiao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanhui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Longfei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiawen","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2026.153252_bb0005","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-080952","article-title":"Projections for prevalence of Parkinson\u2019s disease and its driving factors in 195 countries and territories to 2050: modelling study of global burden of disease study 2021","volume":"388","author":"Su","year":"2025","journal-title":"Bmj"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0010","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1097\/JCMA.0000000000001146","article-title":"Clinical characteristics and treatment of psychosis in Parkinson\u2019s disease: a narrative review","volume":"87","author":"Stamenovi\u0107","year":"2024","journal-title":"J. Chin. Med. Assoc."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0015","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1093\/brain\/awae303","article-title":"Delineating three distinct spatiotemporal patterns of brain atrophy in Parkinson's disease","volume":"147","author":"Sakato","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0020","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.ncl.2024.12.007","article-title":"Motor features of Parkinson\u2019s disease","volume":"43","author":"Tarakad","year":"2025","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0025","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ncl.2024.12.010","article-title":"Treatment of motor symptoms of Parkinson\u2019s disease","volume":"43","author":"Marsili","year":"2025","journal-title":"Neurol. Clin."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.176819","article-title":"Experimental models of Parkinson\u2019s disease: challenges and opportunities","volume":"980","author":"Lal","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/s12974-024-03210-8","article-title":"Suppression of the JAK\/STAT pathway inhibits neuroinflammation in the line 61-PFF mouse model of Parkinson\u2019s disease","volume":"21","author":"Hong","year":"2024","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0040","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1038\/s41586-025-08845-y","article-title":"Phase I trial of hES cell-derived dopaminergic neurons for Parkinson's disease","volume":"641","author":"Tabar","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0045","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41582-019-0244-7","article-title":"Ageing as a risk factor for neurodegenerative disease","volume":"15","author":"Hou","year":"2019","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0050","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/mds.30162","article-title":"Update on treatments for Parkinson\u2019s disease motor fluctuations - an international Parkinson and movement disorder society evidence-based medicine review","volume":"40","author":"de Bie","year":"2025","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0055","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0140-6736(24)02808-3","article-title":"Exenatide once a week versus placebo as a potential disease-modifying treatment for people with Parkinson's disease in the UK: a phase 3, multicentre, double-blind, parallel-group, randomised, placebo-controlled trial","volume":"405","author":"Vijiaratnam","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0060","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1080\/14740338.2024.2418950","article-title":"Drug-induced parkinsonism: diagnosis and treatment","volume":"23","author":"Conn","year":"2024","journal-title":"Expert Opin. Drug Saf."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0065","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.1016\/j.neuron.2024.06.029","article-title":"Microglia rescue neurons from aggregate-induced neuronal dysfunction and death through tunneling nanotubes","volume":"112","author":"Scheiblich","year":"2024","journal-title":"Neuron"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0070","doi-asserted-by":"crossref","first-page":"3306","DOI":"10.1093\/brain\/awae177","article-title":"The immune system in Parkinson's disease: what we know so far","volume":"147","author":"Roodveldt","year":"2024","journal-title":"Brain"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0075","article-title":"Bioactive peptide hydrogel scaffold with high fluidity, thermosensitivity, and neurotropism in 3D spatial structure for promoted repair of spinal cord injury","volume":"21","author":"Sun","year":"2025","journal-title":"Small"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0080","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.4103\/1673-5374.391313","article-title":"Emerging strategies for nerve repair and regeneration in ischemic stroke: neural stem cell therapy","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0085","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.7150\/thno.103033","article-title":"Revisiting the unobtrusive role of exogenous stem cells beyond neural circuits replacement in spinal cord injury repair","volume":"15","author":"Wen","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0090","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1007\/s10753-024-02125-z","article-title":"MicroRNAs modulating neuroinflammation in Parkinson\u2019s disease","volume":"48","author":"Saadh","year":"2025","journal-title":"Inflammation"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0095","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.1021\/acschemneuro.5c00313","article-title":"Exosomes and their miRNA as a potential biomarker in the diagnosis of Parkinson\u2019s disease","volume":"16","author":"Vijayakumar","year":"2025","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0100","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/s41531-024-00791-2","article-title":"MicroRNAs regulation in Parkinson's disease, and their potential role as diagnostic and therapeutic targets","volume":"10","author":"Shaheen","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0105","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.ijbiomac.2022.12.217","article-title":"Identification of novel glucocerebrosidase chaperone for potential treatment of Parkinson\u2019s disease: an approach using in silico virtual screening, molecular docking and molecular dynamics, and in vitro studies","volume":"228","author":"Tripathi","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0110","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.4103\/1673-5374.390959","article-title":"The advantages of multi-level omics research on stem cell-based therapies for ischemic stroke","volume":"19","author":"Wang","year":"2024","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0115","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2024.1485722","article-title":"Identification of biomarkers in Parkinson\u2019s disease by comparative transcriptome analysis and WGCNA highlights the role of oligodendrocyte precursor cells","volume":"16","author":"Zhang","year":"2024","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.105871","article-title":"Generation of wild-type rat Glucocerebrosidase homology modeling: identification of putative interactions site and mechanism for chaperone using combined in-silico and in-vitro studies","volume":"126","author":"Tripathi","year":"2022","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0125","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1093\/stmcls\/sxae042","article-title":"Advancing Parkinson\u2019s disease treatment: cell replacement therapy with neurons derived from pluripotent stem cells","volume":"42","author":"Clark","year":"2024","journal-title":"Stem Cells"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0130","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1038\/s41582-024-01034-x","article-title":"Parkinson disease therapy: current strategies and future research priorities","volume":"20","author":"Stocchi","year":"2024","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2021.121075","article-title":"Restoring mammary gland structures and functions with autogenous cell therapy","volume":"277","author":"Zhang","year":"2021","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0140","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s13024-023-00699-0","article-title":"Unravelling cell type-specific responses to Parkinson\u2019s disease at single cell resolution","volume":"19","author":"Martirosyan","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0145","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/s41531-023-00628-4","article-title":"Candidate biomarkers of EV-microRNA in detecting REM sleep behavior disorder and Parkinson's disease","volume":"10","author":"Li","year":"2024","journal-title":"NPJ Parkinsons Dis."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0150","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abo1997","article-title":"Single-cell transcriptomic and proteomic analysis of Parkinson\u2019s disease brains","volume":"16","author":"Zhu","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0155","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.7150\/thno.107436","article-title":"Epigenetic regulation-mediated disorders in dopamine transporter endocytosis: a novel mechanism for the pathogenesis of Parkinson\u2019s disease","volume":"15","author":"Liang","year":"2025","journal-title":"Theranostics"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0160","article-title":"The class-IIa HDAC inhibitor TMP269 promotes BMP-Smad signalling and is neuroprotective in in vitro and in vivo 6-hydroxydopamine models of Parkinson\u2019s disease","volume":"268","author":"O\u2019Mahony","year":"2025","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177123","article-title":"Neuroprotective potential of epigenetic modulators, its regulation and therapeutic approaches for the management of Parkinson\u2019s disease","volume":"985","author":"Kumari","year":"2024","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0170","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s13040-024-00391-z","article-title":"Deep learning-based approaches for multi-omics data integration and analysis","volume":"17","author":"Ballard","year":"2024","journal-title":"BioData Min."},{"key":"10.1016\/j.ijbiomac.2026.153252_bb0175","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.7150\/thno.92700","article-title":"Forskolin-driven conversion of human somatic cells into induced neurons through regulation of the cAMP-CREB1-JNK signaling","volume":"14","author":"Wang","year":"2024","journal-title":"Theranostics"}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026031922?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0141813026031922?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T17:14:21Z","timestamp":1787850861000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0141813026031922"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":35,"alternative-id":["S0141813026031922"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153252","relation":{},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-omics integration combined with multi-source weighted analysis identifies a key microRNA combination that reverses \u03b1-synuclein aggregation and pathological phenotypes in Parkinson's disease","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2026.153252","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"153252"}}